Healthcare & Life Sciences
Context Therapeutics
United Statescontexttherapeutics.com
aliveseries-c-plus
series-c-plus
Stage
1
Investors
About
Context Therapeutics develops clinical-stage bispecific T cell engager antibody therapies targeting solid tumors to activate the immune system for cancer treatment.
Explore Context Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.